glp-1 agonist alzheimer's Microdosing, Brain Health & Prevention GLP-1 receptor agonists show promise

The rationale for a GLP-1 drug is its powerful body-wide and brain anti-inflammatory properties, says Eric Topol, a cardiologist and the director of the La Jolla, California-based Scripps Research Translational Institute, which is sponsoring the trial

Most pharmacokinetic studies assessing the brain uptake of incretin mimetics have been conducted in animals, and translating these findings to human subjects and clinical outcomes remains uncertain

How sleep triggers GLP-1: Sleep acts like a reset button for your hormones

The drug was first approved in 2010, but the problem was that a patient had to inject it daily

doi: 10.1371/journal.pone.0025269

We know that patients who are treated with GLP-1RA are much less likely to die from any cause than patients treated with DPP-IV inhibitors and sulfonylureas